![](/img/cover-not-exists.png)
Ibrutinib for the treatment of Mantle Cell Lymphoma (MCL): evaluating the correlation between patient-reported outcomes and durability of response in a Phase 2 study
Rule, S., Goy, A., Martin, P., Ramchandren, R., Alexeeva, J., Popat, R., Avivi, I., Advani, R., Le Gouill, S., Horowitz, N., Yuan, Z., Kranenburg, B., Zhuang, S.H., Deraedt, W., Rizo, A., Wildgust, M.Volume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.03.1750
Date:
May, 2015
File:
PDF, 71 KB
english, 2015